No Data
No Data
Day One Biopharmaceuticals(DAWN.US) Officer Sells US$160.06K in Common Stocks
$Day One Biopharmaceuticals(DAWN.US)$ Officer Blackman Samuel C. sold 10,000 shares of Common Stocks on Mar 25, 2024 at an average price of $16.0055 for a total value of $160.06K.Source: Announcement
Day One Biopharm Price Target Maintained With a $40.00/Share by Piper Sandler
Day One Biopharm Price Target Maintained With a $40.00/Share by Piper Sandler
Express News | Piper Sandler Maintains Overweight on Day One Biopharmaceutical, Maintains $40 Price Target
Day One Biopharmaceutical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/26/2024 165.96% Piper Sandler $40 → $40 Maintains Overweight 02/28/2024 165.96% Piper Sandler $45 → $40
Analysts' Opinions Are Mixed on These Healthcare Stocks: Day One Biopharmaceuticals (DAWN), BioMarin Pharmaceutical (BMRN) and Argenx Se (ARGX)
We're Not Very Worried About Day One Biopharmaceuticals' (NASDAQ:DAWN) Cash Burn Rate
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring
No Data